Tags |
|
|
Links |
|
|
Summary - Redux Lawyer Discusses Fen-Phen Fad
In the early nineties, Redux was the original miracle diet pill. A predecessor to fenphen, Redux was just the “fen”, f
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
enfluramine in the form dexfenfluramine. The drug increased the production of seratonin, which gave the brain feelings
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
of satiety, or fullness. Overweight people felt a great responsibility lifted from their shoulders. In Redux, the dru
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
g industry promised a thin, healthy body without painful exercise or unpleasant diet restrictions! Within three months
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
doctors were writing 85,000 prescriptions for Redux every week.
We now know how this story ends. Like most miracle d
We now know how this story ends. Like most miracle d
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
rugs, Redux was too good to be true. The increase of seratonin caused people using Redux to be moody and disconsolate.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
Soon the fenfluramine cocktail drug fenphen replaced Redux on the shelves. This is not the end of the story, however.
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
Soon after thousands of Americans had swallowed fenphen pills, the mortality reports began coming in.
Redux and fenp
Redux and fenp
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
en work the same way, by flooding the brain with chemicals that trigger that full feeling. Because the patient feels f
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ull, they do not feel the need to eat. The drug imparts a comfortable form of anorexia. While this is unhealthy in and
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
of itself, denying the patient essential nutrients, it was not the worst aspect of the drug. The drug did not simply
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
elevate seratonin levels in the brain, it flooded the whole blood stream with seratonin. When this chemical reached th
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
heart it weakened the heart valves, causing massive heart valve disease in people using either fenfluramine drug, Red
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ux or fenphen.
When this deadly side effect became known the drugs were immediately recalled, but the damage was alre
When this deadly side effect became known the drugs were immediately recalled, but the damage was alre
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ady done. Thousands of people developed heart disease, underwent surgery, or died as a result of their exposure to the
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
chemical. Those patients who did not change their habits to include healthy lifestyle choices like exercise and diet
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
estrictions gained the weight back. Nothing very good came of America’s brief affair with fenfluramine.
People are st
People are st
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ill suffering from heart disease as a result of this drug. If you or someone you know is a victim, contact a lawyer an
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
d discuss your circumstances. The drug companies should repay you for your pain and medical costs. Hopefully America w
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ill not simply forget this brief affair with fenfluramine and be more careful about the pills we swallow so carelessly
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.summary.org.ua/article/253235/summary-Redux-Lawyer-Discusses-FenPhen-Fad.html">Redux Lawyer Discusses Fen-Phen Fad</a>
BB link (for phorums):
[url=http://www.summary.org.ua/article/253235/summary-Redux-Lawyer-Discusses-FenPhen-Fad.html]Redux Lawyer Discusses Fen-Phen Fad[/url]
Related Articles:
Why Use A Health Insurance Broker
Investing In Real Estate Investors
Bookmark it:
|